- Previous Close
600.92 - Open
602.63 - Bid 597.56 x 1100
- Ask 598.38 x 800
- Day's Range
596.83 - 603.99 - 52 Week Range
415.60 - 627.88 - Volume
243,152 - Avg. Volume
1,349,131 - Market Cap (intraday)
228.659B - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
37.18 - EPS (TTM)
16.10 - Earnings Date Oct 23, 2024
- Forward Dividend & Yield 1.56 (0.26%)
- Ex-Dividend Date Sep 13, 2024
- 1y Target Est
653.16
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
www.thermofisher.com122,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TMO
View More
Performance Overview: TMO
Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TMO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TMO
View MoreValuation Measures
Market Cap
229.55B
Enterprise Value
256.13B
Trailing P/E
37.28
Forward P/E
25.06
PEG Ratio (5yr expected)
2.24
Price/Sales (ttm)
5.47
Price/Book (mrq)
4.84
Enterprise Value/Revenue
6.05
Enterprise Value/EBITDA
22.00
Financial Highlights
Profitability and Income Statement
Profit Margin
14.69%
Return on Assets (ttm)
4.83%
Return on Equity (ttm)
13.53%
Revenue (ttm)
42.35B
Net Income Avi to Common (ttm)
6.22B
Diluted EPS (ttm)
16.10
Balance Sheet and Cash Flow
Total Cash (mrq)
8.82B
Total Debt/Equity (mrq)
74.53%
Levered Free Cash Flow (ttm)
6.52B
Research Analysis: TMO
View MoreCompany Insights: TMO
TMO does not have Company Insights
Research Reports: TMO
View MoreU.S. stocks indices are lower at midday on Friday, seemingly on track to
U.S. stocks indices are lower at midday on Friday, seemingly on track to end a very busy week on the downside for the day -- but solidly higher for the week. With the most-recent interest-rate impact having now been felt, next month's start of earnings season, the ongoing presidential-election newsfeed, and volatile geopolitical events appear to be the likely catalysts for investors in the days and weeks ahead.
Argus Quick Note: Weekly Stock List for 08/26/2024: Inside the Minds of the Big Guns
Vickers Stock Research, a subsidiary of Argus Research Group, analyzes insider trading and institutional stock ownership. Form 13Fs, which institutions must file to report their holdings, are due 45 days after the end of calendar quarters and have come in for 2Q24. We review 13Fs of major institutional investors, including activists, to see what they are buying and to look for trends. Activist investing is now less about generating a short-term return and more about achieving long-term returns through an active management/investor partnership. The stock-market volatility during 2Q gave those institutional investors a chance to buy a dip. Taking a look at the 13Fs from well-known institutional portfolios, we see that the big guns were busy, either adding new holdings or increasing existing holdings. Buying was across a variety of sectors. Based on Vickers data, the following are select purchases made in 2Q by some high-profile money managers. We also list one significant sale (of Apple by Berkshire) and also note if the holding is now 4% or more of the total portfolio.
Daily – Vickers Top Buyers & Sellers for 07/30/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Thermo Fisher Earnings: More of the Same, Second Half Should Return to Growth
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
RatingPrice Target